Clinical Utility of SCALE-B to Predict Hepatitis B Virus Relapse, Hepatitis B Surface Antigen Loss After Antiviral Cessation in Asian Patients After 2-Year Follow-up

BACKGROUND: Discontinuation of antiviral therapy in chronic hepatitis B (CHB) patients leads to a higher hepatitis B surface antigen (HBsAg) loss; yet, clinical relapse (CR) may occur. SCALE-B score was developed to predict off-treatment CR; however, validation of SCALE-B beyond a 48-week follow-up...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewdech, Apichat, Assawasuwannakit, Suraphon, Sripongpun, Pimsiri, Chamroonkul, Naichaya, Tangkijvanich, Pisit, Piratvisuth, Teerha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987127/
https://www.ncbi.nlm.nih.gov/pubmed/35402452
http://dx.doi.org/10.3389/fmed.2022.859430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987127/
https://www.ncbi.nlm.nih.gov/pubmed/35402452
http://dx.doi.org/10.3389/fmed.2022.859430

Ejemplares similares